Myriad Genetics, Inc. (MYGN) vs REGENXBIO Inc. (RGNX)
A side-by-side comparison of Myriad Genetics, Inc. and REGENXBIO Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
MYGN
Myriad Genetics, Inc.
$4.28HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
RGNX
REGENXBIO Inc.
$7.45HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — MYGN vs RGNX
growth of $100 · dividends reinvested · last 10yMYGN -77.8% (-14.0%/yr)RGNX -52.1% (-7.1%/yr)RGNX compounded faster over this window
MYGN RGNX
MYGN vs RGNX: by the numbers
- •MYGN is the larger company ($404M vs $385M market cap).
- •Both run net losses; MYGN's is the smaller (-13.96% vs -112.58% net margin).
- •MYGN grew revenue faster over the past five years (9.70% vs 1.59% CAGR).
Metrics side by side
Valuation
| Metric | MYGN | RGNX |
|---|---|---|
| P/S ratio | 0.50 | 2.21 |
| P/B ratio | 1.33 | 5.37 |
Profitability
| Metric | MYGN | RGNX |
|---|---|---|
| Gross margin | 68.83% | 88.09% |
| Operating margin | -12.22% | -94.08% |
| Net margin | -13.96% | -112.58% |
| ROE | -37.05% | -273.72% |
| ROIC | -19.13% | -54.00% |
Growth (annualized)
| Metric | MYGN | RGNX |
|---|---|---|
| Revenue CAGR (5Y) | 9.70% | 1.59% |
| Total return CAGR (5Y) | -32.02% | -24.15% |
Frequently asked
- Which has grown faster, MYGN or RGNX?
- Over the past five years, MYGN grew revenue faster — MYGN at a 9.70% CAGR versus RGNX at 1.59%.
- How have MYGN and RGNX total returns compared?
- Over the past 10 years, MYGN delivered -14.20% and RGNX delivered -6.47% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.